Adult and paediatric cough guidelines

Ready for an overhaul?

Surinder S. Birring, David Kavanagh, Lai Kefang, Anne Chang

Research output: Contribution to journalArticleResearchpeer-review

5 Downloads (Pure)

Abstract

Cough is one of the most common reasons that patients seek medical attention. Cough guidelines from numerous countries and societies are available to assist the clinician to investigate and manage patients with cough. We review some of the recent progress in the field of cough that may lead to revision of these guidelines. In adults with chronic cough, new causes such as obstructive sleep apnoea have been identified. A new terminology, cough hypersensitivity syndrome (CHS), has been proposed for patients with chronic cough, which emphasises cough reflex hypersensitivity as a key feature. New therapeutic options are now available, particularly for patients with refractory or idiopathic chronic cough, which include gabapentin, speech pathology management and morphine. There has been great progress in the assessment of cough with the development of validated quality of life questionnaires and cough frequency monitoring tools. In children, common aetiologies differ from adults and those managed according to guidelines have better outcomes compared to usual care. New diagnostic entities such as protracted bacterial bronchitis have been described. Paediatric-specific cough assessment tools such as the Parent/Child Quality of Life Questionnaire will help improve the assessment of patients. Further research is necessary to improve the evidence base for future clinical guideline recommendations. Guidelines in future should also aim to reach a wider audience that includes primary care physicians, non-specialists and patients.
Original languageEnglish
Pages (from-to)137-144
Number of pages8
JournalPulmonary Pharmacology and Therapeutics
Volume35
DOIs
Publication statusPublished - 2015

Fingerprint

Pediatrics
Cough
Guidelines
Pathology
Terminology
Refractory materials
Morphine
Monitoring
Hypersensitivity
Quality of Life
Speech-Language Pathology
Bronchitis
Primary Care Physicians
Obstructive Sleep Apnea
Reflex
Sleep
gabapentin

Cite this

Birring, Surinder S. ; Kavanagh, David ; Kefang, Lai ; Chang, Anne. / Adult and paediatric cough guidelines : Ready for an overhaul?. In: Pulmonary Pharmacology and Therapeutics. 2015 ; Vol. 35. pp. 137-144.
@article{a685136139b64986ba17576ed0708c70,
title = "Adult and paediatric cough guidelines: Ready for an overhaul?",
abstract = "Cough is one of the most common reasons that patients seek medical attention. Cough guidelines from numerous countries and societies are available to assist the clinician to investigate and manage patients with cough. We review some of the recent progress in the field of cough that may lead to revision of these guidelines. In adults with chronic cough, new causes such as obstructive sleep apnoea have been identified. A new terminology, cough hypersensitivity syndrome (CHS), has been proposed for patients with chronic cough, which emphasises cough reflex hypersensitivity as a key feature. New therapeutic options are now available, particularly for patients with refractory or idiopathic chronic cough, which include gabapentin, speech pathology management and morphine. There has been great progress in the assessment of cough with the development of validated quality of life questionnaires and cough frequency monitoring tools. In children, common aetiologies differ from adults and those managed according to guidelines have better outcomes compared to usual care. New diagnostic entities such as protracted bacterial bronchitis have been described. Paediatric-specific cough assessment tools such as the Parent/Child Quality of Life Questionnaire will help improve the assessment of patients. Further research is necessary to improve the evidence base for future clinical guideline recommendations. Guidelines in future should also aim to reach a wider audience that includes primary care physicians, non-specialists and patients.",
author = "Birring, {Surinder S.} and David Kavanagh and Lai Kefang and Anne Chang",
year = "2015",
doi = "10.1016/j.pupt.2015.01.007",
language = "English",
volume = "35",
pages = "137--144",
journal = "Pulmonary Pharmacology and Therapeutics",
issn = "1094-5539",
publisher = "Academic Press",

}

Adult and paediatric cough guidelines : Ready for an overhaul? / Birring, Surinder S.; Kavanagh, David; Kefang, Lai; Chang, Anne.

In: Pulmonary Pharmacology and Therapeutics, Vol. 35, 2015, p. 137-144.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Adult and paediatric cough guidelines

T2 - Ready for an overhaul?

AU - Birring, Surinder S.

AU - Kavanagh, David

AU - Kefang, Lai

AU - Chang, Anne

PY - 2015

Y1 - 2015

N2 - Cough is one of the most common reasons that patients seek medical attention. Cough guidelines from numerous countries and societies are available to assist the clinician to investigate and manage patients with cough. We review some of the recent progress in the field of cough that may lead to revision of these guidelines. In adults with chronic cough, new causes such as obstructive sleep apnoea have been identified. A new terminology, cough hypersensitivity syndrome (CHS), has been proposed for patients with chronic cough, which emphasises cough reflex hypersensitivity as a key feature. New therapeutic options are now available, particularly for patients with refractory or idiopathic chronic cough, which include gabapentin, speech pathology management and morphine. There has been great progress in the assessment of cough with the development of validated quality of life questionnaires and cough frequency monitoring tools. In children, common aetiologies differ from adults and those managed according to guidelines have better outcomes compared to usual care. New diagnostic entities such as protracted bacterial bronchitis have been described. Paediatric-specific cough assessment tools such as the Parent/Child Quality of Life Questionnaire will help improve the assessment of patients. Further research is necessary to improve the evidence base for future clinical guideline recommendations. Guidelines in future should also aim to reach a wider audience that includes primary care physicians, non-specialists and patients.

AB - Cough is one of the most common reasons that patients seek medical attention. Cough guidelines from numerous countries and societies are available to assist the clinician to investigate and manage patients with cough. We review some of the recent progress in the field of cough that may lead to revision of these guidelines. In adults with chronic cough, new causes such as obstructive sleep apnoea have been identified. A new terminology, cough hypersensitivity syndrome (CHS), has been proposed for patients with chronic cough, which emphasises cough reflex hypersensitivity as a key feature. New therapeutic options are now available, particularly for patients with refractory or idiopathic chronic cough, which include gabapentin, speech pathology management and morphine. There has been great progress in the assessment of cough with the development of validated quality of life questionnaires and cough frequency monitoring tools. In children, common aetiologies differ from adults and those managed according to guidelines have better outcomes compared to usual care. New diagnostic entities such as protracted bacterial bronchitis have been described. Paediatric-specific cough assessment tools such as the Parent/Child Quality of Life Questionnaire will help improve the assessment of patients. Further research is necessary to improve the evidence base for future clinical guideline recommendations. Guidelines in future should also aim to reach a wider audience that includes primary care physicians, non-specialists and patients.

U2 - 10.1016/j.pupt.2015.01.007

DO - 10.1016/j.pupt.2015.01.007

M3 - Article

VL - 35

SP - 137

EP - 144

JO - Pulmonary Pharmacology and Therapeutics

JF - Pulmonary Pharmacology and Therapeutics

SN - 1094-5539

ER -